Press release
Global Congenital Heart Disease Market Research and Forecast 2018-2023
Congenital Heart Disease Market
According to the OMR analysis, the global congenital heart disease market is growing at a significant rate during 2018-2023. The global congenital heart disease market has witnessed a significant growth due to increasing rising prevalence of congenital heart disease. The global congenital heart disease market is segmented on the basis of defect type, diagnosis, treatment, end user and geography. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis and analyst insights.
Full report of global congenital heart disease market is available at https://www.omrglobal.com/industry-reports/congenital-heart-disease-market/
“The most common type of birth defect is congenital heart defects which affects 8 out of every 1,000 newborns in the US. Each year, more than 35,000 babies in the US are born with congenital heart defects. Congenital heart defects involve the valves of the heart, the walls of the heart, and the arteries and veins near the heart. The defect can interrupt the regular blood flow through the heart. The blood flow can go in the wrong direction or to the wrong place, slow down, or be blocked completely. However, with innovative advances in diagnosis and treatment, most children can live healthy and productive lives. Some need special care all though their lives to maintain a good quality of life.”
The global congenital heart disease market on the basis of geography is divided among four major regions – North America, APAC, Europe, and Rest of the world. North America is the leading the market. North American market is driven by rising healthcare expenditure and increasing investment in healthcare. Asia Pacific market is expected to have the highest CAGR amongst all regions during the forecast period of 2018-2023. The increasing prevalence of diabetes in APAC region due to changing lifestyle standards is supporting growth of this region.
The report covers
Comprehensive research methodology of global congenital heart disease market
In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global congenital heart disease market
Insights about market determinants which are stimulating the global congenital heart disease market
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players
For related reports please visit https://www.omrglobal.com/reports-category/healthcare/
For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/
About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
Contact us
Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com, support@omrglobal.com
India: +91-780-304-0404, +91-917-982-8694
Global:+1-646-755-7667
Indore-India-452010
Web: www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Congenital Heart Disease Market Research and Forecast 2018-2023 here
News-ID: 1487396 • Views: …
More Releases from Orion Market Research
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Congenital
Maternal Diabetes Driving Congenital Heart Disease Market Growth: A Significant …
The Congenital Heart Disease (CHD) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Congenital Heart Disease (CHD) Market Size and Projected Growth Rate?
The congenital heart disease (CHD) market will increase from $4.42 billion in 2024 to $4.87 billion in 2025, growing at…
Leading Growth Driver in the Congenital Heart Disease (CHD) Market in 2025: Mate …
What Are the Market Size and Growth Forecast for the Congenital Heart Disease (CHD) Market?
The market size for congenital heart disease (CHD) has seen a rapid expansion in the recent years. It's projected to increase from $4.42 billion in 2024 to $4.87 billion in 2025, marking a compound annual growth rate (CAGR) of 10.1%. Factors contributing to the growth during the historical period include a rise in risk factors like…
Congenital Diarrheal Disorders Market Outlook Report 2032 by DelveInsight
DelveInsight's "Congenital Diarrheal Disorders Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Congenital Diarrheal Disorders, historical and forecasted epidemiology as well as the Congenital Diarrheal Disorders market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Congenital Diarrheal Disorders market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted…
Understanding the Congenital Hyperinsulinism Market: Size, Trends, and Insights
Congenital Hyperinsulinism (CHI) is an exceedingly rare genetic disorder that impacts individuals from birth. It is characterized by the overproduction of insulin by the pancreas, leading to persistent and severe hypoglycemia. The CHI market is of significant importance not only for healthcare professionals but also for affected individuals and their families. This article provides a detailed analysis of the CHI market, covering aspects such as market size, trends, segmentation, and…
Leber Congenital Amaurosis Market by Players and Application 2024
Leber Congenital Amaurosis Market: Overview
Leber congenital amaurosis (LCA) is a disorder of eye mainly affects the retina. Retina is the specific tissue at the back of the eye responsible for detection of light and color. People, primarily babies suffering with this disorder have severe visual impairment from the first year of life. The visual impairment because of this disorder likely to be stable for the rest of the life, whereas…
Congenital Heart Disease-Pipeline Insights, 2017
Orbis Research released a new research report of 60 pages on title “Congenital Heart Disease-Pipeline Insights, 2017” Report Focuses on Market, Status and Forecast, by Players, Types and Applications’ with detailed analysis, forecast and strategies.
“Congenital Heart Disease-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Congenital Heart Disease. The Report covers the product profiles in various stages of development including…
